ArticleScientific reports2025
Development and validation of a risk prediction model for pulmonary tuberculosis in presumptive tuberculosis patients in Tigray, northern Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prevalence and determinants of tuberculosis and COVID-19 among patients with presumptive tuberculosis in a Nigerian tertiary hospital.BMC infectious diseases · 2026Article
- A Clinical Prediction Model for Atypical Tuberculosis Manifestations Among Older Adults.Medicina (Kaunas, Lithuania) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of tuberculosis (TB) has increased in Tigray, Ethiopia due to war and a crippled healthcare system. Although early detection and treatment are critical for TB control, over 30% of TB cases are missed using current diagnostic techniques. Thus, we developed and validated a risk prediction model for pulmonary TB in presumptive cases. In this multicenter cross-sectional study, we consecutively enrolled 907 respondents from primary healthcare facilities in Tigray, northern Ethiopia. We used least absolute shrinkage and selection operator regression to identify variables for the model. Risk scores were generated from the coefficients of multivariable logistic regression. We evaluated the model performance using the area under the curve and calibration plots, and clinical utility using decision curves. Among all respondents, 155 (17%) had GeneXpert-confirmed pulmonary TB. At an optimal cutoff value of 8.5, the model demonstrated a discrimination accuracy of 0.82 (95% CI: 0.78-0.85), a sensitivity of 82.6%, and a specificity of 68.9%. The model had a calibration slope of 0.98 and an intercept of 0.001. The model exhibits acceptable discrimination and calibration performance. Thus, it can be used for screening patients for pulmonary TB in primary healthcare settings where accurate diagnostic resources are limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.